[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338467-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338467-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","whole-exome-sequencing-reveals-genomic-landscape-of-intrahepatic-cholangiocarcinoma-and-identifies-sav1-as-a-potential-driver","Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver","","Whole-exome sequencing is used to characterize the genomic landscape of 204 Chinese primary intrahepatic cholangiocarcinoma (ICC) tumors using matched non-cancerous liver tissue. The study identifies 21,772 somatic coding SNVs and 1,302 indels, defines mutation and copy-number patterns, and estimates tumor mutation burden to relate it to prognosis. Six mutational signatures are detected, and 13 significantly mutated genes are reported, including SAV1. SAV1 is linked to reduced protein levels, higher recurrence rates, shorter overall survival, and functional tumor-suppressor effects through Hippo-YAP pathway activation, promoting growth and metastasis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/whole-exome-sequencing-reveals-genomic-landscape-of-intrahepatic-cholangiocarcinoma-and-identifies-sav1-as-a-potential-driver/338467/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/whole-exome-sequencing-reveals-genomic-landscape-of-intrahepatic-cholangiocarcinoma-and-identifies-sav1-as-a-potential-driver/338467.png","ImageObject",300,407,{"name":42,"@type":43},"Seraphina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How many Chinese ICC patients were analyzed in the deep whole-exome sequencing study?","Question",{"text":63,"@type":64},"Deep whole-exome sequencing was performed on 204 Chinese primary ICCs using matched non-cancerous liver tissue samples.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is SAV1’s relationship to patient outcomes in these ICC samples?",{"text":68,"@type":64},"SAV1 is mutated in 2.9% of ICC samples, and SAV1 mutation is associated with lower SAV1 protein levels, higher tumor recurrence rates, and shorter overall patient survival.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the study explain SAV1’s functional role in tumor growth and metastasis?",{"text":72,"@type":64},"Biofunctional investigations indicate SAV1 acts as a tumor suppressor: its inactivation suppresses Hippo signaling, activates YAP, and thereby promotes tumor growth and metastasis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338467,1790164109,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Article [https://doi.org/10.1038/s41467-024-54387-8](https://doi.org/10.1038/s41467-024-54387-8)  \nWhole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identiﬁes SAV1 as a potential driver  \nReceived: 27 January 2022  \n\n| Accepted: 7 November 2024 |\n| --- |\n| |\n| Check for updates |\n\nZheng-Jun Zhou1,2,4, Yu-Hang Ye1,2,4, Zhi-Qiang Hu1,2,4, Yue-Ru Hou3,4,  \nKai-Xuan Liu1,2, Rong-Qi Sun1,2, Peng-Cheng Wang1,2, Chu-Bin Luo1,2, Jia Li1,2, Ji-Xue Zou2, Jian Zhou 1,2, Jia Fan1,2, Cheng-Li Song3  & Shao-Lai Zhou 1,2   \nIntrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malignancy after hepatocellular carcinoma, with poor prognosis and limited treatment options. The genomic features of ICC in Chinese patients remain largely unknown. In this study, we perform deep whole-exome sequencing of 204 Chinese primary ICCs and characterize genomic alterationsand clonal evolution, and reveal their associations with patient outcomes. We identify six mutational signatures, including Signatures A and F, which are highly similar to previously described signatures linked to aristolochic acid and aﬂatoxin exposures, respectively. We also identify 13 signiﬁcantly mutated genes in the ICC samples, including SAV1. We ﬁnd that SAV1 was mutated in 2.9%(20/672) of 672 ICC samples. SAV1 mutation is associated with lower SAV1 protein levels, higher rates of tumor recurrence, and shorter overall patient survival. Biofunctional investigations reveal a tumor-suppressor role of SAV1: its inactivation suppresses Hippo signaling, leading to YAP activation, thereby promoting tumor growth and metastasis. Collectively, our results delineate the genomic landscape of Chinese ICCs and identify SAV1 as a potential driver of ICC.  \nIntrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malignancy after hepatocellular carcinoma (HCC) and has an increasing incidence worldwide1,2. Advances in diagnostic modalities and clinical screening have made early detection and curative resection of ICC possible; however, long-term patient survival is still poor because of high relapse rates3,4. Recently, several pioneering studies expanded our understanding of ICC pathogenesis atthe molecular level by delineating the landscape of genetic alterations that underlie ICC carcinogenesis5–11. However, most of these studies contained limited numbers of ICC samples, and the patients were from  \nmultiple countries with different epidemiological and ancestral backgrounds. Furthermore, most of the studies used targeted sequencing, and whole-exome sequencing (WES)or whole-genome sequencing was only performed with low coverage. More importantly, exhaustive follow-up was performed on very few of the patients. These shortcomings may impede the discovery of potential drivers of ICC, as well as hinder the exploration of potential etiological factors contribute to genetic alterations and their association with patient outcomes.  \nIn this work, we aim to systematically deﬁne genomic alterationsin Chinese patients with ICC. We perform deep WES on 204 Chinese  \n1Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China. 2Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China. 3Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China. 4These authors contributed equally:  \nZheng-Jun Zhou, Yu-Hang Ye, Zhi-Qiang Hu, Yue-Ru Hou. e-mail: [songchengli@dmu.edu.cn](songchengli@dmu.edu.cn); [zhoushaolai99@sina.com](zhoushaolai99@sina.com)  \nprimary ICCs and analyze the associations of genomic alterations with tumor progression and patient outcomes. Focusing on a potential driver of ICC, SAV1, we perform Sanger sequencing to evaluate all the SAV1 coding exons in an additional 468 ICC specimens. We also investigate the functional effects and associated mechanisms of SAV1 on tumor growth and metastasis. Collectively, our results delineate th","cbCaianYvB24RnF6","https://ap.wps.com/l/cbCaianYvB24RnF6","pdf",4619726,15,"English","# Results\n## Overview of genomic alterations in patients with primary ICC\n## Mutational signatures","[{\"question\":\"How many Chinese ICC patients were analyzed in the deep whole-exome sequencing study?\",\"answer\":\"Deep whole-exome sequencing was performed on 204 Chinese primary ICCs using matched non-cancerous liver tissue samples.\"},{\"question\":\"What is SAV1’s relationship to patient outcomes in these ICC samples?\",\"answer\":\"SAV1 is mutated in 2.9% of ICC samples, and SAV1 mutation is associated with lower SAV1 protein levels, higher tumor recurrence rates, and shorter overall patient survival.\"},{\"question\":\"How does the study explain SAV1’s functional role in tumor growth and metastasis?\",\"answer\":\"Biofunctional investigations indicate SAV1 acts as a tumor suppressor: its inactivation suppresses Hippo signaling, activates YAP, and thereby promotes tumor growth and metastasis.\"}]","Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver | PDF",1790023744,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8800e0ae2f8d7d1b93ba2da87fbf078.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6573966d5c818833553edc26748f4311.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf14956c7116d6663ecb479e2fd2948a.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e41cbb14d29fdca0e0f4a3a85478da8a.webp",980,1301]